カテゴリー： QYResearch, 世界

乳がん診断および薬物技術の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18241）・商品コード：DATA909X18241
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、乳がん診断および薬物技術の世界市場について調査・分析し、乳がん診断および薬物技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（マンモグラフィ、生検、その他）、用途別（乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の乳がん診断および薬物技術市場動向
・主要企業別マーケットシェア
・乳がん診断および薬物技術の種類別市場規模2014-2019
（マンモグラフィ、生検、その他）
・乳がん診断および薬物技術の用途別市場規模2014-2019
（乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん）
・乳がん診断および薬物技術の北米市場：主要企業・種類別/用途別市場規模
・乳がん診断および薬物技術のヨーロッパ市場：主要企業・種類別/用途別市場規模
・乳がん診断および薬物技術の中国市場：主要企業・種類別/用途別市場規模
・乳がん診断および薬物技術の日本国内市場：主要企業・種類別/用途別市場規模
・乳がん診断および薬物技術の東南アジア市場：主要企業・種類別/用途別市場規模
・乳がん診断および薬物技術のインド市場：主要企業・種類別/用途別市場規模
・乳がん診断および薬物技術の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Abbott、Roche、BioMerieux、Becton Dickinson、GE Healthcare、Hologic、Philips、PerkinElmer、Quest Diagnostics）
・乳がん診断および薬物技術の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Diagnostic and Drug Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics

Market segment by Type, the product can be split into
Mammography
Biopsy
Other

Market segment by Application, split into
Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players.
To present the Breast Cancer Diagnostic and Drug Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Breast Cancer Diagnostic and Drug Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (2014-2025)
1.4.2 Mammography
1.4.3 Biopsy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2025)
1.5.2 Ductal Carcinoma of Breast
1.5.3 Invasive Ductal Carcinoma
1.5.4 Lobular Carcinoma
1.5.5 Triple Negative Breast Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Breast Cancer Diagnostic and Drug Technologies Market Size
2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Regions
2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (2019-2025)
2.2.2 Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Breast Cancer Diagnostic and Drug Technologies Market Size by by Players
3.1.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue by by Players (2014-2019)
3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by by Players (2014-2019)
3.1.3 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)
3.2 Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Area Served
3.3 Key Players Breast Cancer Diagnostic and Drug Technologies Product/Solution/Service
3.4 Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2014-2019)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2014-2019)

5 North America
5.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
5.2 Breast Cancer Diagnostic and Drug Technologies Key Players in North America
5.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type
5.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application

6 Europe
6.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
6.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Europe
6.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type
6.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application

7 China
7.1 China Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
7.2 Breast Cancer Diagnostic and Drug Technologies Key Players in China
7.3 China Breast Cancer Diagnostic and Drug Technologies Market Size by Type
7.4 China Breast Cancer Diagnostic and Drug Technologies Market Size by Application

8 Japan
8.1 Japan Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
8.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Japan
8.3 Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Type
8.4 Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
9.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Southeast Asia
9.3 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type
9.4 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application

10 India
10.1 India Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
10.2 Breast Cancer Diagnostic and Drug Technologies Key Players in India
10.3 India Breast Cancer Diagnostic and Drug Technologies Market Size by Type
10.4 India Breast Cancer Diagnostic and Drug Technologies Market Size by Application

11 Central & South America
11.1 Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size (2014-2019)
11.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Central & South America
11.3 Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Type
11.4 Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019))
12.1.5 Abbott Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.2.5 Roche Recent Development
12.3 BioMerieux
12.3.1 BioMerieux Company Details
12.3.2 Company Description and Business Overview
12.3.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.3.5 BioMerieux Recent Development
12.4 Becton Dickinson
12.4.1 Becton Dickinson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.4.5 Becton Dickinson Recent Development
12.5 GE Healthcare
12.5.1 GE Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.5.5 GE Healthcare Recent Development
12.6 Hologic
12.6.1 Hologic Company Details
12.6.2 Company Description and Business Overview
12.6.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.6.5 Hologic Recent Development
12.7 Philips
12.7.1 Philips Company Details
12.7.2 Company Description and Business Overview
12.7.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.7.5 Philips Recent Development
12.8 PerkinElmer
12.8.1 PerkinElmer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.8.5 PerkinElmer Recent Development
12.9 Quest Diagnostics
12.9.1 Quest Diagnostics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Breast Cancer Diagnostic and Drug Technologies Introduction
12.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
12.9.5 Quest Diagnostics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Breast Cancer Diagnostic and Drug Technologies Key Market Segments
Table Key Players Breast Cancer Diagnostic and Drug Technologies Covered
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Mammography Figures
Table Key Players of Mammography
Figuer Biopsy Figures
Table Key Players of Biopsy
Figuer Other Figures
Table Key Players of Other
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application in 2018 & 2025
Figure Ductal Carcinoma of Breast Case Studies
Figure Invasive Ductal Carcinoma Case Studies
Figure Lobular Carcinoma Case Studies
Figure Triple Negative Breast Cancer Case Studies
Figure Breast Cancer Diagnostic and Drug Technologies Report Years Considered
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions 2019-2025 (Million US$)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions 2019-2025 (Million US$)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions 2014-2019
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions 2014-2019
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue by by Players (2014-2019) (Million US$)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Share by by Players (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Share by by Players in 2018
Table Global Breast Cancer Diagnostic and Drug Technologies by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Breast Cancer Diagnostic and Drug Technologies Product/Solution/Service
Table Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2014-2019) (Million US$)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Type (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2014-2019) (Million US$)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Application (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application in 2018
Figure North America Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table North America Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table North America Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Figure Europe Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table Europe Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table Europe Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Figure China Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table China Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table China Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table China Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table China Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table China Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table China Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Figure Japan Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table Japan Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table Japan Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table Japan Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table Japan Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Figure Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Figure India Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table India Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table India Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table India Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table India Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table India Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table India Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Figure Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2018-2019)
Table Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Type 2014-2019 (Million US$)
Table Central & South America Breast Cancer Diagnostic and Drug Technologies Market Share by Type 2014-2019
Table Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Application 2014-2019 (Million US$)
Table Central & South America Breast Cancer Diagnostic and Drug Technologies Market Share by Application 2014-2019
Table Abbott Company Details
Table Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table Abbott Recent Development
Table Roche Company Details
Table Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table Roche Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure BioMerieux Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table BioMerieux Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure Becton Dickinson Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table Becton Dickinson Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure GE Healthcare Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table GE Healthcare Recent Development
Table Hologic Company Details
Table Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure Hologic Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table Hologic Recent Development
Table Philips Company Details
Table Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure Philips Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table Philips Recent Development
Table PerkinElmer Company Details
Table PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure PerkinElmer Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table PerkinElmer Recent Development
Table Quest Diagnostics Company Details
Table Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business 2014-2019 (Million US$)
Figure Quest Diagnostics Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2014-2019)
Table Quest Diagnostics Recent Development
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (Million US$) 2019-2025
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Regions (2019-2025)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Regions in 2025
Figure North America Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Figure China Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Figure India Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2025)(Million USD)
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Product (2019-2025) (Million US$)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size by Product (2019-2025)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size by Product in 2025
Table Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2025) (Million US$)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2025)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abbott、Roche、BioMerieux、Becton Dickinson、GE Healthcare、Hologic、Philips、PerkinElmer、Quest Diagnostics

★調査レポート[乳がん診断および薬物技術の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18241)販売に関する免責事項を必ずご確認ください。
★調査レポート[乳がん診断および薬物技術の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 乳がん検査の世界市場：規模・現状・予測2019-2025
    DATA909X18242 / QYResearch / 2019年11月25日 / ※当調査レポートでは、乳がん検査の世界市場について調査・分析し、乳がん検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（スクリーニングテスト、診断テスト、モニタリングテスト）、用途別（非浸潤性乳がん、浸潤性乳がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん検査市場動向 ・主要企業別マーケットシェア ・乳がん検査の種類別市場規模2014-2019 （スクリーニングテスト、診断テスト、モニタリングテスト） ・乳がん検査の用途別市場規模2014-2019 （非浸潤性乳がん、浸潤性乳がん） ・乳がん検査の北米市場：主要企業・種類別/用途別市場規模 ・乳がん検査のヨーロッパ市場：主要企業・種類別/用途別市場規模...Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected...
  • ホルモン抵抗性乳癌の世界市場：規模・現状・予測2019-2025
    DATA909X18546 / QYResearch / 2019年11月25日 / ※当調査レポートでは、ホルモン抵抗性乳癌の世界市場について調査・分析し、ホルモン抵抗性乳癌の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腫瘍マーカー療法、遺伝子発現療法、遺伝子突然変異療法）、用途別（科学研究生産、生物科学技術、医療技術、医療機器）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のホルモン抵抗性乳癌市場動向 ・主要企業別マーケットシェア ・ホルモン抵抗性乳癌の種類別市場規模2014-2019 （腫瘍マーカー療法、遺伝子発現療法、遺伝子突然変異療法） ・ホルモン抵抗性乳癌の用途別市場規模2014-2019 （科学研究生産、生物科学技術、医療技術、医療機器） ・ホルモン抵抗性乳癌の北米市場：主要企業・種類別/用途別市場規模 ・ホルモン抵抗性乳癌のヨーロッパ市場：主要企業・種類別/用途別市場規模...An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-cancer pipeline drugs, all of which drive the growth of hormone-refractory breast cancer market.In 2018, the global Hormone Refractory Breast Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hormone Refractory Breast Cancer status, future...
  • 膵臓がん診断装置の世界市場：規模・現状・予測2019-2025
    DATA909X18794 / QYResearch / 2019年11月25日 / ※当調査レポートでは、膵臓がん診断装置の世界市場について調査・分析し、膵臓がん診断装置の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（イメージング、腫瘍バイオマーカー、生検、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膵臓がん診断装置市場動向 ・主要企業別マーケットシェア ・膵臓がん診断装置の種類別市場規模2014-2019 （イメージング、腫瘍バイオマーカー、生検、その他） ・膵臓がん診断装置の用途別市場規模2014-2019 （病院、クリニック、その他） ・膵臓がん診断装置の北米市場：主要企業・種類別/用途別市場規模 ・膵臓がん診断装置のヨーロッパ市場：主要企業・種類別/用途別市場規模...Imaging tests that create pictures of your internal organs. These tests help your doctors visualize your internal organs, including the pancreas. Techniques used to diagnose pancreatic cancer include ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and, sometimes, positron emission tomography (PET) scans.In 2018, the global Pancreatic Cancer Diagnostic Devices market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pancreatic Cancer Diagnostic Devices status, future forecast, growth opportunity, key market and key players. The study...

    • ◆H&Iグローバルリサーチのお客様（例）◆